Impact of Different Types of Virtual Reality Games on Motion Sickness and Ocular in Adults: A Pilot Study
Launched by HE EYE HOSPITAL · Apr 8, 2024
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
1. Title: The Impact of Immersive Virtual Reality Training on Adult: Motion Sickness, and Ocular Surface: A Pilot Study.
2. Purpose: To evaluate the initial safety impact of head-mounted virtual reality (HMVR) devices with virtual reality amblyopia training games on postural stability, motion sickness, and ocular surface in healthy adult participants.
3. Methods: A total of 38 healthy adult volunteers (18 males, 20 females) aged 18-42 years old were recruited from Shenyang He Eye Specialist Hospital from July to August 2023. Inclusion criteria: age ≥18 years; BCVA \>=1.0; Titmus is between ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>= 18
- • Best vision \>=1.0
- • Titmus is between 40s and 60s
- Exclusion Criteria:
- • History of eye surgery and trauma within 3 months
- • Active eye diseases
- • Pregnancy and lactation period
- • Allergic to fluorescein sodium
- • The researcher determined that the subjects were not suitable for this study
About He Eye Hospital
The Eye Hospital is a leading clinical research institution dedicated to advancing the field of ophthalmology through innovative clinical trials and cutting-edge research. With a commitment to improving patient outcomes and enhancing vision health, the hospital collaborates with renowned experts and utilizes state-of-the-art technology to explore new therapies and treatment modalities. By prioritizing patient care and safety, The Eye Hospital plays a pivotal role in translating scientific discoveries into effective clinical practices, thereby contributing significantly to the global understanding of eye diseases and their management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenyang, Liaoning, China
Patients applied
Trial Officials
Ling Xu, MD
Principal Investigator
He Eye Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported